Rise in Cannabis-Related Emergency Visits for Older Adults From 2005 to 2019
Authors say providers should routinely ask older adults about cannabis use
Diagnosis & Disease Information
FDA Says No to Regulating CBD Products as Supplements
How to regulate CBD supplements has become a pressing public health concern as the popularity of CBD supplements has exploded in the United States
No Increase Seen in OD Deaths Involving Buprenorphine During COVID-19
Proportion of overdose deaths did not increase in association with actions taken to ease access to buprenorphine
Rate of Opioid Rx at Discharge From Emergency Department Declining
Decrease seen in rate and percentage of emergency department visits with opioid prescribed at discharge from 2017-2018 to 2019-2020
Intranasal Nalmefene Gets Priority Review for Opioid Overdose Treatment
OPNT003 is an intranasal formulation containing the high affinity opioid antagonist, nalmefene.
Pediatric Cannabis Poisoning Increased With Edible Cannabis Sales
Canadian provinces permitting edible cannabis sales experienced much larger increases in hospitalizations for unintentional poisoning
Cannabis Legalization Tied to Increases in Pediatric Asthma
Increases seen compared with states where neither recreational nor medical legalization has occurred
Buprenorphine-Naloxone Appears Safe for Maternal Opioid Use Disorder
Maternal, neonatal outcomes similar to buprenorphine monotherapy
December 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in December 2022 for investigational products in development.
Recommendations Developed Relating to Cannabis Use Before Surgery
Universal screening for cannabinoids recommended before surgery; elective surgery should be postponed in some cases
